Rebate agreements for active ingredient combination Emtricitabine/Tenofovir disoproxil/Rilpivirine
Status
Active
Submission Deadline
108 days remaining
Contracting authority
Techniker Krankenkasse144 more open tenders view
Location
Hamburg, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-565249-2026
Source
Rebate agreements according to § 130c para. 1 SGB V: Conclusion with suitable pharmaceutical companies for the active ingredient combination Emtricitabine/Tenofovir disoproxil/Rilpivirine.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 565249-2026HTML
- TED PDF — 565249-2026PDF
- TED XML — 565249-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Not allowed
Legal Basis
32014L0024